Physician profile
John A Kruba
NPI 1922092923
$1,611.74
in general payments reported to CMS, 2019-2025
24 companies · $15.21 in 2025
The $15.21 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,262 · 2020: $242 · 2021: $28.48 · 2022: $63.75 · 2025: $15.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $234.09 | 2019-2020 | |
| Glaxosmithkline, LLC. | $217.35 | 2019-2020 | |
| Janssen Biotech, INC. | $169.05 | 2019-2020 | |
| Viiv Healthcare Company | $133.49 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $128.61 | 2019-2020 | |
| Pfizer INC. | $111.22 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $75.91 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $72.06 | 2019 | |
| Novo Nordisk INC | $70.41 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.59 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $51.37 | 2019-2021 | |
| Abbvie INC. | $45.34 | 2019-2025 | |
| Astellas Pharma US INC | $41.29 | 2019-2020 | |
| Amgen INC. | $35.56 | 2019 | |
| Theratechnologies INC. | $32.32 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.86 | 2022 | |
| Therapeuticsmd, INC. | $16.51 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.21 | 2019 | |
| Emd Serono, INC. | $16.16 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.17 | 2019 | |
| Lilly USA, LLC | $15.05 | 2019 | |
| Napo Pharmaceuticals INC | $12.48 | 2019 | |
| Horizon Therapeutics Plc | $11.84 | 2019 | |
| Antares Pharma, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kruba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.